— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

venBio Partners LLC

Q3 2025 · Filed 2025-11-14
Market Value
$61M
+54.5%
Holdings
5
-1
New Purchases
0
Added To
0
Closed
0
Reduced
0
Top 10 Concentration
100.0%
Turnover
0.0%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ALXO 29.27% 10.25% +19.01% $18M
LYEL 12.68% 10.66% +2.02% $8M
ARTV 5.44% 4.42% +1.02% $3M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
HRMY 22.23% 39.37% -17.14% $13M
ALMS 30.39% 35.30% -4.91% $18M

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $13M 22.2%
Small Cap 2 $22M 35.8%
Micro Cap 2 $25M 41.9%

Portfolio Analytics

Avg Market Cap
$773M
Median Market Cap
$334M
Avg P/E
12.7
Median P/E
12.7
Avg Dividend Yield
—%
Avg Beta
0.56
# Stocks
5
# ETFs / Funds
0

Top Holdings (5 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ALMS 30.39% 4,619,803 $18M $3.99 $5M — —
2 ALXO 29.27% 9,699,925 $18M $1.83 $14M — —
3 HRMY 22.23% 489,194 $13M $27.56 -$2M — —
4 LYEL 12.68% 473,479 $8M $16.24 $4M — —
5 ARTV 5.44% 1,148,975 $3M $2.87 $2M — —
View SEC EDGAR Filings for venBio Partners LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms